Clinical Trial

High-power Laser Therapy for Notalgia Paresthetica.

Recruiting
View on ClinicalTrials.gov →
Summary
A non-invasive modality for the management of neuromusculoskeletal pain conditions that has emerged as a compelling option is high-power laser therapy (HPLT). The pathophysiology of notalgia paresthetica (NP) is treated uniquely by HPLT, which targets both the presumed muscular component of nerve entrapment and the resultant neuropathic symptoms. The main goal of this study, which is randomised, controlled and blinded by assessors, is to find out how well High-Power Laser Therapy (HPLT) works as an extra treatment to standard care in reducing itching, pain and improving quality of life for patients with long-term nerve pain.
Protocol Amendment History 1 change
critical Recruitment opened 2026-07-21
Trial Details
NCT Number NCT07356362
Lead Sponsor Uşak University
Collaborators: Balikesir University
Conditions Notalgia Paresthetica
Enrollment 40 participants
Start Date 2026-07-17
Primary Completion 2026-10-23 (estimated)
Study Completion 2026-11-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-20